Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis

被引:157
|
作者
Lemoine, M. [1 ]
Katsahian, S. [2 ]
Ziol, M. [3 ]
Nahon, P. [1 ]
Ganne-Carrie, N. [1 ]
Kazemi, F. [1 ]
Grando-Lemaire, V. [1 ]
Trinchet, J. -C. [1 ]
Beaugrand, M. [1 ]
机构
[1] Hop Jean Verdier, AP HP, Serv Hepatol, F-93143 Bondy, France
[2] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France
[3] Hop Jean Verdier, Dept Anatomopathol, F-93143 Bondy, France
关键词
D O I
10.1111/j.1365-2036.2008.03825.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT). Liver stiffness measurement (LSM) is a non-invasive method for liver fibrosis assessment. Aims To assess the relationship between LSM and HVPG in patients with compensated cirrhosis related to hepatitis C virus (HCV) or alcohol and to define the performance and the best cut-off of LSM for the diagnosis of PHT in these patients. Methods Between January 2004 and September 2006, we studied all the consecutive patients with compensated HCV or alcohol-related-cirrhosis referred for transjugular liver biopsy with HVPG measurement and LSM performed the same day. Results Ninety-two patients were eligible, 44 had HCV related-cirrhosis and 48 alcoholic cirrhosis. LSM was positively correlated to HVPG in both groups. The area under the receiver operating characteristic curve for the diagnosis of significant PHT was 0.76 +/- 0.07 in HCV patients (best cut-off at 20.5 kPa) and 0.94 +/- 0.03 (best cut-off at 34.9 kPa) in alcoholic patients. Conclusions Liver stiffness measurement and HVPG were significantly correlated in patients with compensated cirrhosis because of HCV infection or alcohol. LSM could predict significant PHT in both these groups of patients with a higher cut-off and a better performance in alcoholic patients.
引用
收藏
页码:1102 / 1110
页数:9
相关论文
共 50 条
  • [41] Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Sharma, Sanchit
    Agarwal, Samagra
    Anand, Abhinav
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (05): : 1096 - 1097
  • [42] BACTERIAL INFECTIONS IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION: IMPLICATIONS ON THE RISK OF DEVELOPING DECOMPENSATION AND ON SURVIVAL.
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Carlos Garcia-Pagan, Juan
    Luis Calleja, Jose
    Aracil, Carles
    Banares Canizares, Rafael
    Morillas, Rosa
    Poca Sans, Maria
    Penas, B.
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    HEPATOLOGY, 2019, 70 : 36A - 37A
  • [43] Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis
    Rodrigues, Susana G.
    Montani, Matteo
    Guixe-Muntet, Sergi
    De Gottardi, Andrea
    Berzigotti, Annalisa
    Bosch, Jaime
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2101 - +
  • [44] Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
    Sturm, Lukas
    Bettinger, Dominik
    Roth, Lisa
    Zoldan, Katharina
    Stolz, Laura
    Gahm, Chiara
    Huber, Jan Patrick
    Reincke, Marlene
    Kaeser, Rafael
    Boettler, Tobias
    Kreisel, Wolfgang
    Thimme, Robert
    Schultheiss, Michael
    FRONTIERS IN MEDICINE, 2022, 8
  • [45] THE INTERVAL CHANGE OF LIVER STIFFNESS MEASUREMENT IS USEFUL IN PREDICTION OF THE THERAPEUTIC RESPONSE OF PROPRANOLOL IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
    Kim, Moon Young
    Baik, Soon Koo
    Park, So Yeon
    Kim, Bo Ra
    Jo, Ki Won
    Hong, Jin Heon
    HEPATOLOGY, 2011, 54 : 1234A - 1234A
  • [46] Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
    Pastrovic, Frane
    Novak, Rudjer
    Grgurevic, Ivica
    Hrkac, Stela
    Salai, Grgur
    Zarak, Marko
    Grgurevic, Lovorka
    PLOS ONE, 2024, 19 (04):
  • [47] Non-invasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis (vol 103, pg 1159, 2008)
    Berzigotti
    Gilabert
    Abraldes
    Nicolau
    Bru
    Bosch
    Garcia-Pagan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08): : 2167 - 2167
  • [48] A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
    Dajti, Elton
    Ravaioli, Federico
    Marasco, Giovanni
    Alemanni, Luigina Vanessa
    Colecchia, Luigi
    Ferrarese, Alberto
    Cusumano, Caterina
    Gemini, Stefano
    Vestito, Amanda
    Renzulli, Matteo
    Golfieri, Rita
    Festi, Davide
    Colecchia, Antonio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (11): : 1825 - 1833
  • [49] Sequential algorithm of spleen stiffness measured by a dedicated 100 Hz examination and Baveno VII criteria for clinically significant portal hypertension in compensated cirrhosis
    He, Ruiling
    Liu, Chuan
    Jie, Li
    Ma, Jianzhong
    Guo, Ying
    Guo, Xiaoqing
    Liu, Shirong
    Gao, Bo
    Liu, Ning
    Chen, Mingkai
    Zhou, Hongwei
    Tang, Tianyu
    Shi, Yu
    Ju, Shenghong
    Yan Huadong
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2022, 77 : S636 - S636
  • [50] THE PROTEIN FINGERPRINT TECHNOLOGY REFLECTS LIVER FUNCTION AND DETECTS CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS
    Nielsen, M. J.
    Leeming, D. J.
    Karsdal, M. A.
    Trebicka, J.
    Byrjalsen, I.
    Bendtsen, F.
    Moller, S.
    Krag, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S96 - S97